Fundz

Memed Raises $93M To Accelerate Commercialization Of Its Host Immune-Response Product Portfolio

PRIVATEJan 10, 2022

Amount Raised

$93 Million

Round Type

Funding Round

United StatesInformation TechnologySustainabilitySoftwareData And AnalyticsHealth Care

Description

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

Quick answer

Memed raised $93 Million in a Funding Round round, dated January 10, 2022. Memed is based in United States.

How much did Memed raise?
Memed raised $93 Million in a Funding Round round on January 10, 2022.
What does Memed do?
MeMed has also developed the MeMed COVID-19 Severity™ test for predicting severe outcomes in COVID-19 patients, which has been cleared for use in Europe.
Where is Memed based and how big is it?
Memed is based in United States. Fundz records about 27 employees.
Who are the decision-makers at Memed?
Fundz holds 1 contact at Memed, including the Strategic Marketing. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Sustainability and Data And Analytics around the same time

Companies in the same sectors as Memed that raised within 45 days of this round, from Fundz verified event records.

  • 6 Estates raised $6.2M (Series B) on February 21, 2022.
  • Prelude raised $9.3M on February 15, 2022.
  • kWh Analytics raised $20M (Funding Round) on February 8, 2022.
  • Koneksa Health raised $45M (Series C) on February 7, 2022.
  • Addionics raised $27M (Series A) on January 25, 2022.
  • Heaps Health Solutions raised $7.5M (Series A) on January 17, 2022.

Who to call at Memed, and when

A new round usually means Memed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Memed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Memed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Memed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Memed

Location

United States

About

MeMed has also developed the MeMed COVID-19 Severity™ test for predicting severe outcomes in COVID-19 patients, which has been cleared for use in Europe. Eran Eden, MeMed’s co-founder and CEO, said: “This new investment will enable MeMed to expand operations with a focus on the U.S.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Memed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDaniel E., Strategic MarketingSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Memed's next move

See what Strategic adds

Memed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.